NCT05290519

Brief Summary

The investigators will try to evaluate the effects of substitution of dietary animal protein by black soybean milk (400 mL x 2) per day on anthropocentric and metabolic parameters in obese subjects.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 1, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

March 1, 2022

Completed
21 days until next milestone

First Posted

Study publicly available on registry

March 22, 2022

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

March 22, 2022

Status Verified

March 1, 2022

Enrollment Period

10 months

First QC Date

March 1, 2022

Last Update Submit

March 13, 2022

Conditions

Keywords

advanced glycation end productsobesityplant proteininflammationgut microbiota

Outcome Measures

Primary Outcomes (6)

  • change from 4week blood advanced glycation end products level at 8 week

    blood AGEs level will be measured before and after intervention

    4, 8 week

  • change from 12 week blood advanced glycation end products level at 16 week

    blood AGEs level will be measured before and after intervention

    12, 16 week

  • change from 4 week blood leptin level at 8 week

    blood leptin level will be measured before and after intervention

    4, 8 week

  • change from 12 week blood leptin level at 16 week

    blood leptin level will be measured before and after intervention

    12, 16 week

  • change from 4 week blood adiponectin level at 8 week

    blood leptin level will be measured before and after intervention

    4, 8 week

  • change from 12 week blood adiponectin level at 16 week

    blood leptin level will be measured before and after intervention

    12, 16 week

Study Arms (2)

Group A

EXPERIMENTAL

plant protein for 4 weeks than animal protein for 4 weeks

Other: plant and animal protein

Group B

EXPERIMENTAL

animal protein for 4 weeks than plant protein for 4 weeks

Other: plant and animal protein

Interventions

plant protein: 2 bottle of black soy milk (400 mL/bottle) for 4 weeks animal protein: pork dished for 4 weeks

Group AGroup B

Eligibility Criteria

Age20 Years - 64 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • to 64 year male or female
  • \<= BMI \< 35 or waist circumference male \>= 90 cm/female \>= 80 cm
  • fasting blood glucose: 100-125 mg/dL

You may not qualify if:

  • Hypertension, cardiovascular disease, endocrine disease, acute and chronic liver and kidney disease, mental disease, binge or anorexia, or long-term drug use
  • Consume probiotics, prebiotics, antibiotics or weight loss drugs regularly for the past month
  • Try to lose weight and do resistance exercise regularly for the past month
  • Allergic to soy products

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan Normal University

Taipei, 106, Taiwan

RECRUITING

Related Publications (1)

  • Chang YH, Lee PN, Chen CH, Yang HY, Wu CH, Doong JY, Yeh WJ. Substituting animal protein with black soymilk reduces advanced glycation end product level and improves gut microbiota composition in obese prediabetic individuals: a randomized crossover intervention trial. Food Funct. 2025 Jan 2;16(1):195-206. doi: 10.1039/d4fo04717f.

MeSH Terms

Conditions

Obesity, AbdominalInflammationObesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsPathologic Processes

Study Officials

  • Wan-Ju Yeh

    National Taiwan Normal University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 1, 2022

First Posted

March 22, 2022

Study Start

March 1, 2022

Primary Completion

December 31, 2022

Study Completion

December 31, 2022

Last Updated

March 22, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

IPD will be published in journals

Locations